Brief: IPCA Laboratories Gives USFDA Inspection Update Of Piparia Formulations Manufacturing Facility
24/08/2023 04:48
Aug 24 (Reuters) - IPCA Laboratories Ltd IPCA.NS :
* USFDA INSPECTION UPDATE OF PIPARIA FORMULATIONS
MANUFACTURING
FACILITY
* US FDA HAVE DETERMINED INSPECTION CLASSIFICATION OF
MANUFACTURING FACILITY AS "VOLUNTARY ACTION INDICATED
* FACILITY CONSIDERED TO BE IN MINIMALLY ACCEPTABLE STATE OF
COMPLIANCE WITH REGARDS TO CURRENT GOOD MANUFACTURING PRACTICE
Source text for Eikon: ID:nBSE76D1jM
Further company coverage: IPCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ipca Laboratories
See all newsBrief: Ipca Labs March-Quarter Consol Net Profit 3 Billion Rupees
Brief: Ipca Labs Posts Dec-Qtr Consol Net PAT 3.26 Billion Rupees
Brief: IPCA Labs Says US FDA Issues Form 483 With Three Observations
Brief: IPCA Labs Sept-Quarter Consol Net Pat 2.83 Billion Rupees
Brief: IPCA Labs Says To Sell Unit In Ankleshwar For 221.5 Mln Rupees